Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer

This study is currently recruiting participants.

Verified January 2012 by Harbin Medical University

Study NCT01483300 Information provided by Harbin Medical University

First Received on November 25, 2011. Last Updated on January 22, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

Interventions listed in this trial

lobaplatin
cisplatin

Additional drug interventions recognized in this trial

Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial